Bioton S.A. (BIO) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.017x

Based on the latest financial reports, Bioton S.A. (BIO) has a cash flow conversion efficiency ratio of 0.017x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł9.98 Million ≈ $2.75 Million USD) by net assets (zł588.01 Million ≈ $161.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Bioton S.A. - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Bioton S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Bioton S.A. debt and liabilities for a breakdown of total debt and financial obligations.

Bioton S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioton S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Yuen Chang Stainless Steel Co Ltd
TW:2069
0.023x
Tat Gida Sanayi AS
IS:TATGD
0.249x
Hyosung Itx
KO:094280
0.064x
E & M Computing Ltd
TA:EMCO
0.118x
Sound Financial Bancorp Inc
NASDAQ:SFBC
0.018x
seha corporation
KO:027970
0.076x
DRTECH Corporation
KQ:214680
-0.050x
ABC Taiwan Electronics
TWO:3236
0.045x

Annual Cash Flow Conversion Efficiency for Bioton S.A. (2005–2024)

The table below shows the annual cash flow conversion efficiency of Bioton S.A. from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see Bioton S.A. market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 zł590.55 Million
≈ $162.53 Million
zł36.33 Million
≈ $10.00 Million
0.062x -5.86%
2023-12-31 zł606.36 Million
≈ $166.88 Million
zł39.62 Million
≈ $10.91 Million
0.065x -29.38%
2022-12-31 zł606.06 Million
≈ $166.80 Million
zł56.08 Million
≈ $15.43 Million
0.093x +943.56%
2021-12-31 zł622.74 Million
≈ $171.39 Million
zł5.52 Million
≈ $1.52 Million
0.009x -86.90%
2020-12-31 zł619.64 Million
≈ $170.54 Million
zł41.95 Million
≈ $11.54 Million
0.068x -15.64%
2019-12-31 zł582.00 Million
≈ $160.17 Million
zł46.71 Million
≈ $12.85 Million
0.080x +105.18%
2018-12-31 zł712.79 Million
≈ $196.17 Million
zł27.88 Million
≈ $7.67 Million
0.039x +72.80%
2017-12-31 zł773.25 Million
≈ $212.81 Million
zł17.50 Million
≈ $4.82 Million
0.023x -20.41%
2016-12-31 zł813.83 Million
≈ $223.98 Million
zł23.15 Million
≈ $6.37 Million
0.028x -4.50%
2015-12-31 zł806.64 Million
≈ $222.00 Million
zł24.02 Million
≈ $6.61 Million
0.030x +2.81%
2014-12-31 zł1.45 Billion
≈ $397.84 Million
zł41.87 Million
≈ $11.52 Million
0.029x -49.82%
2013-12-31 zł1.39 Billion
≈ $381.20 Million
zł79.96 Million
≈ $22.01 Million
0.058x -46.71%
2012-12-31 zł1.34 Billion
≈ $367.86 Million
zł144.80 Million
≈ $39.85 Million
0.108x +775.77%
2011-12-31 zł1.38 Billion
≈ $381.14 Million
zł-22.20 Million
≈ $-6.11 Million
-0.016x -169.02%
2010-12-31 zł1.17 Billion
≈ $321.97 Million
zł27.17 Million
≈ $7.48 Million
0.023x +131.27%
2009-12-31 zł1.08 Billion
≈ $297.22 Million
zł-80.22 Million
≈ $-22.08 Million
-0.074x -343.58%
2008-12-31 zł1.24 Billion
≈ $340.63 Million
zł37.74 Million
≈ $10.39 Million
0.030x +5202.64%
2007-12-31 zł886.79 Million
≈ $244.06 Million
zł-530.00K
≈ $-145.86K
-0.001x +95.51%
2006-12-31 zł808.11 Million
≈ $222.40 Million
zł-10.76 Million
≈ $-2.96 Million
-0.013x -147.73%
2005-12-31 zł255.42 Million
≈ $70.29 Million
zł7.13 Million
≈ $1.96 Million
0.028x --

About Bioton S.A.

WAR:BIO Poland Biotechnology
Market Cap
$98.54 Million
zł358.05 Million PLN
Market Cap Rank
#19240 Global
#153 in Poland
Share Price
zł4.17
Change (1 day)
+0.00%
52-Week Range
zł3.74 - zł4.65
All Time High
zł15.39
About

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes m… Read more